228 related articles for article (PubMed ID: 12097485)
1. Prostaglandin E2 is a novel inducer of oncostatin-M expression in macrophages and microglia.
Repovic P; Benveniste EN
J Neurosci; 2002 Jul; 22(13):5334-43. PubMed ID: 12097485
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide.
Repovic P; Mi K; Benveniste EN
Glia; 2003 Jun; 42(4):433-46. PubMed ID: 12730964
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E₂ induces oncostatin M expression in human chronic wound macrophages through Axl receptor tyrosine kinase pathway.
Ganesh K; Das A; Dickerson R; Khanna S; Parinandi NL; Gordillo GM; Sen CK; Roy S
J Immunol; 2012 Sep; 189(5):2563-73. PubMed ID: 22844123
[TBL] [Abstract][Full Text] [Related]
4. PGE2 induces IL-1beta gene expression in mouse osteoblasts through a cAMP-PKA signaling pathway.
Park YG; Kang SK; Noh SH; Park KK; Chang YC; Lee YC; Kim CH
Int Immunopharmacol; 2004 Jun; 4(6):779-89. PubMed ID: 15135319
[TBL] [Abstract][Full Text] [Related]
5. TNF-alpha/IFN-gamma-induced iNOS expression increased by prostaglandin E2 in rat primary astrocytes via EP2-evoked cAMP/PKA and intracellular calcium signaling.
Hsiao HY; Mak OT; Yang CS; Liu YP; Fang KM; Tzeng SF
Glia; 2007 Jan; 55(2):214-23. PubMed ID: 17091492
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 inhibits advanced glycation end product-induced adhesion molecule expression, cytokine production, and lymphocyte proliferation in human peripheral blood mononuclear cells.
Takahashi HK; Liu K; Wake H; Mori S; Zhang J; Liu R; Yoshino T; Nishibori M
J Pharmacol Exp Ther; 2009 Nov; 331(2):656-70. PubMed ID: 19700629
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 induces interleukin-6 expression in human chondrocytes via cAMP/protein kinase A- and phosphatidylinositol 3-kinase-dependent NF-kappaB activation.
Wang P; Zhu F; Konstantopoulos K
Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1445-56. PubMed ID: 20457835
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of prostaglandin E
Mukherjee S; Sengupta Bandyopadhyay S
Biochem J; 2018 Jan; 475(2):477-494. PubMed ID: 29269396
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E(2) upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages.
Hinz B; Brune K; Pahl A
Biochem Biophys Res Commun; 2000 Jun; 272(3):744-8. PubMed ID: 10860826
[TBL] [Abstract][Full Text] [Related]
10. Selective modulation of BV-2 microglial activation by prostaglandin E(2). Differential effects on endotoxin-stimulated cytokine induction.
Petrova TV; Akama KT; Van Eldik LJ
J Biol Chem; 1999 Oct; 274(40):28823-7. PubMed ID: 10497256
[TBL] [Abstract][Full Text] [Related]
11. Oncostatin M regulation of interleukin-6 expression in astrocytes: biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38.
Van Wagoner NJ; Choi C; Repovic P; Benveniste EN
J Neurochem; 2000 Aug; 75(2):563-75. PubMed ID: 10899931
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E(2) inhibits replication of HIV-1 in macrophages through activation of protein kinase A.
Hayes MM; Lane BR; King SR; Markovitz DM; Coffey MJ
Cell Immunol; 2002 Jan; 215(1):61-71. PubMed ID: 12142037
[TBL] [Abstract][Full Text] [Related]
13. Oncostatin M synergises with house dust mite proteases to induce the production of PGE(2) from cultured lung epithelial cells.
Knight DA; Asokananthan N; Watkins DN; Misso NL; Thompson PJ; Stewart GA
Br J Pharmacol; 2000 Oct; 131(3):465-72. PubMed ID: 11015296
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts.
Kojima F; Naraba H; Sasaki Y; Beppu M; Aoki H; Kawai S
Arthritis Rheum; 2003 Oct; 48(10):2819-28. PubMed ID: 14558087
[TBL] [Abstract][Full Text] [Related]
15. Oncostatin M promotes excitotoxicity by inhibiting glutamate uptake in astrocytes: implications in HIV-associated neurotoxicity.
Moidunny S; Matos M; Wesseling E; Banerjee S; Volsky DJ; Cunha RA; Agostinho P; Boddeke HW; Roy S
J Neuroinflammation; 2016 Jun; 13(1):144. PubMed ID: 27287400
[TBL] [Abstract][Full Text] [Related]
16. Regulatory effects of interleukin-1beta and prostaglandin E2 on expression of receptor activator of nuclear factor-kappaB ligand in human periodontal ligament cells.
Nukaga J; Kobayashi M; Shinki T; Song H; Takada T; Takiguchi T; Kamijo R; Hasegawa K
J Periodontol; 2004 Feb; 75(2):249-59. PubMed ID: 15068113
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 1 Tat protein decreases cyclic AMP synthesis in rat microglia cultures.
Patrizio M; Colucci M; Levi G
J Neurochem; 2001 Apr; 77(2):399-407. PubMed ID: 11299302
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E(2) modulation of vascular endothelial growth factor production in murine macrophages.
Mukutmoni M; Hubbard NE; Erickson KL
Prostaglandins Leukot Essent Fatty Acids; 2001 Sep; 65(3):123-31. PubMed ID: 11728162
[TBL] [Abstract][Full Text] [Related]
19. Soluble factors released by Toxoplasma gondii-infected astrocytes down-modulate nitric oxide production by gamma interferon-activated microglia and prevent neuronal degeneration.
Rozenfeld C; Martinez R; Figueiredo RT; Bozza MT; Lima FR; Pires AL; Silva PM; Bonomo A; Lannes-Vieira J; De Souza W; Moura-Neto V
Infect Immun; 2003 Apr; 71(4):2047-57. PubMed ID: 12654825
[TBL] [Abstract][Full Text] [Related]
20. Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1/2-pathway independent of p38(MAPK)/MK2.
Ehlting C; Böhmer O; Hahnel MJ; Thomas M; Zanger UM; Gaestel M; Knoefel WT; Schulte Am Esch J; Häussinger D; Bode JG
Cell Signal; 2015 Mar; 27(3):555-67. PubMed ID: 25562430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
